{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:42:10Z","timestamp":1790775730260,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum fur Infektionsforschung eV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011937","name":"Nieders\u00e4chsisches Ministerium f\u00fcr Wissenschaft und Kultur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004937","name":"Bundesministerium fur Bildung und Forschung Dienststelle Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.cell.2021.12.032","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T01:45:36Z","timestamp":1640310336000},"page":"447-456.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":828,"title":["The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic"],"prefix":"10.1016","volume":"185","author":[{"given":"Markus","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cossmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheila","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Nehlmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luise","family":"Graichen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Sophie","family":"Moldenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Dopfer-Jablonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Martin","family":"J\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg M.N.","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"P\u00f6hlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2021.12.032_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.22619","article-title":"Omicron has reached the US-here's what infectious disease experts know About the variant","author":"Abbasi","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cell.2021.12.032_bib2","series-title":"Tshwane District Omicron variant patient profile - early features","author":"Abdullah","year":"2021"},{"key":"10.1016\/j.cell.2021.12.032_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02107-20","article-title":"Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate","volume":"58","author":"Addetia","year":"2020","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.cell.2021.12.032_bib4","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/s41423-021-00779-5","article-title":"The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency","volume":"18","author":"Arora","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cell.2021.12.032_bib5","doi-asserted-by":"crossref","first-page":"109825","DOI":"10.1016\/j.celrep.2021.109825","article-title":"B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination","volume":"37","author":"Arora","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.cell.2021.12.032_bib6","article-title":"Protection against Covid-19 by BNT162b2 booster across age groups","author":"Bar-On","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.12.032_bib7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41591-021-01449-9","article-title":"Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19\/BNT162b2 vaccination","volume":"27","author":"Barros-Martins","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2021.12.032_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(21)01891-2","article-title":"SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S\/BNT162b2 vaccination","volume":"398","author":"Behrens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2021.12.032_bib9","doi-asserted-by":"crossref","first-page":"e25858","DOI":"10.1371\/journal.pone.0025858","article-title":"A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon","volume":"6","author":"Berger Rentsch","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cell.2021.12.032_bib10","doi-asserted-by":"crossref","first-page":"e0189073","DOI":"10.1371\/journal.pone.0189073","article-title":"The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells","volume":"12","author":"Brinkmann","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cell.2021.12.032_bib11","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.12.032_bib12","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1056\/NEJMoa2114114","article-title":"Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.12.032_bib13","series-title":"Covid: Omicron spreading in the community, Javid confirms","author":"Company","year":"2021"},{"key":"10.1016\/j.cell.2021.12.032_bib14","doi-asserted-by":"crossref","first-page":"eabj0299","DOI":"10.1126\/science.abj0299","article-title":"Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","volume":"373","author":"Corbett","year":"2021","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.cell.2021.12.032_bib65","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2102685","article-title":"Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19","volume":"385","author":"Dougan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cell.2021.12.032_bib15","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2021.12.032_bib16","first-page":"eab3435","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","author":"Gilbert","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.12.032_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-021-03610-3","article-title":"Daily briefing: Omicron was already spreading in Europe","author":"Graham","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.12.032_bib18","article-title":"Probable transmission of SARS-CoV-2 omicron variant in quarantine hotel, Hong Kong, China, November 2021","volume":"28","author":"Gu","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cell.2021.12.032_bib19","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa2107934","article-title":"Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab","volume":"385","author":"Gupta","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.12.032_bib20","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(21)00675-9","article-title":"SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)","volume":"397","author":"Hall","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2021.12.032_bib21","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(21)00575-4","article-title":"Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study","volume":"397","author":"Hansen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2021.12.032_bib22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.abd0827","article-title":"Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail","volume":"369","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.12.032_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamainternmed.2021.0366","article-title":"Association of SARS-CoV-2 seropositive antibody test With risk of future infection","volume":"181","author":"Harvey","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.cell.2021.12.032_bib24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cell.2021.12.032_bib25","series-title":"Understanding Omicron: changes in the spike protein and beyond and what they portend","author":"Haseltine","year":"2021"},{"key":"10.1016\/j.cell.2021.12.032_bib26","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.cell.2021.03.036","article-title":"SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies","volume":"184","author":"Hoffmann","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.12.032_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2021.12.032_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.12.032_bib29","doi-asserted-by":"crossref","first-page":"109017","DOI":"10.1016\/j.celrep.2021.109017","article-title":"SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization","volume":"35","author":"Hoffmann","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.cell.2021.12.032_bib30","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.abe8499","article-title":"SARS-CoV-2 D614G variant exhibits efficient replication ex\u00a0vivo and transmission in\u00a0vivo","volume":"370","author":"Hou","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.12.032_bib31","doi-asserted-by":"crossref","first-page":"103381","DOI":"10.1016\/j.ebiom.2021.103381","article-title":"Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice","volume":"67","author":"Huang","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cell.2021.12.032_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf1906","article-title":"The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates","volume":"13","author":"Jones","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2021.12.032_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01381-18","article-title":"Mutations in the spike protein of Middle East respiratory syndrome coronavirus transmitted in Korea increase resistance to antibody-mediated neutralization","volume":"93","author":"Kleine-Weber","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2021.12.032_bib34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.12.032_bib35","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0140-6736(21)00782-0","article-title":"Correlates of protection from SARS-CoV-2 infection","volume":"397","author":"Krammer","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2021.12.032_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910636","article-title":"The upper respiratory tract of felids is highly susceptible to SARS-CoV-2 infection","volume":"22","author":"Kr\u00fcger","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cell.2021.12.032_bib37","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1126\/science.acx9738","article-title":"Where did 'weird' Omicron come from?","volume":"374","author":"Kupferschmidt","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.12.032_bib38","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.scib.2021.01.011","article-title":"The Rhinolophus affinis bat ACE2 and multiple animal orthologs are functional receptors for bat coronavirus RaTG13 and SARS-CoV-2","volume":"66","author":"Li","year":"2021","journal-title":"Sci. Bull. (Beijing)"},{"key":"10.1016\/j.cell.2021.12.032_bib39","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.cell.2021.02.042","article-title":"SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape","volume":"184","author":"Li","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.12.032_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.chom.2021.01.014","article-title":"Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization","volume":"29","author":"Liu","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2021.12.032_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa2034545","article-title":"Antibody status and incidence of SARS-CoV-2 infection in health care workers","volume":"384","author":"Lumley","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.12.032_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf3671","article-title":"The SARS-CoV-2 Spike variant D614G favors an open conformational state","volume":"7","author":"Mansbach","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cell.2021.12.032_bib43","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.12.032_bib44","doi-asserted-by":"crossref","first-page":"109292","DOI":"10.1016\/j.celrep.2021.109292","article-title":"Recurrent emergence of SARS-CoV-2 spike deletion H69\/V70 and its role in the Alpha variant B.1.1.7","volume":"35","author":"Meng","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.cell.2021.12.032_bib45","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.12.032_bib46","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijid.2021.11.040","article-title":"Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts","volume":"114","author":"Petersen","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.cell.2021.12.032_bib47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.12.032_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","volume":"592","author":"Plante","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.12.032_bib49","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.12.032_bib50","article-title":"Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa","author":"Pulliam","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.cell.2021.12.032_bib51","article-title":"Comparison of four SARS-CoV-2 neutralization assays","volume":"9","author":"Riepler","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.cell.2021.12.032_bib52","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201181","article-title":"Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesSARS-CoV-2","volume":"217","author":"Schmidt","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2021.12.032_bib53","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.12.032_bib54","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1038\/s41467-021-25903-x","article-title":"Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2","volume":"12","author":"Sun","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2021.12.032_bib55","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","article-title":"The biological and clinical significance of emerging SARS-CoV-2 variants","volume":"22","author":"Tao","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cell.2021.12.032_bib56","doi-asserted-by":"crossref","first-page":"n3051","DOI":"10.1136\/bmj.n3051","article-title":"Covid restrictions tighten as omicron cases double every two to three days","volume":"375","author":"Torjesen","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cell.2021.12.032_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2021.12.032_bib58","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.12.032_bib59","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19","volume":"384","author":"Weinreich","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.12.032_bib60","doi-asserted-by":"crossref","first-page":"109822","DOI":"10.1016\/j.celrep.2021.109822","article-title":"Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain","volume":"37","author":"Wheatley","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.cell.2021.12.032_bib61","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109905118","article-title":"Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2021.12.032_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02477-20","article-title":"SARS-CoV-2 rapidly adapts in aged BALB\/c mice and induces typical pneumonia","volume":"95","author":"Zhang","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2021.12.032_bib63","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-021-03361-1","article-title":"SARS-CoV-2 spike D614G change enhances replication and transmission","volume":"592","author":"Zhou","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.12.032_bib64","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867421014951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867421014951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:59:07Z","timestamp":1758801547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867421014951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0092867421014951"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2021.12.032","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.12.472286","asserted-by":"object"}]},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2021.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2021.12.033","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}